| Literature DB >> 32434568 |
Mina Pourmbarak Mahnaie1, Hassan Mahmoudi2.
Abstract
BACKGROUND: Biofilm formation is regarded as a significant factor in the establishment of infections caused by Pseudomonas aeruginosa. P. aeruginosa is one of the most important causes of nosocomial infections. Today silver nanoparticles (Ag-NPs) are used as antimicrobials due to their well-known, chemical, biological, and physical properties. Exposure to nanoparticles could inhibit colonization of new bacteria onto the biofilm.Entities:
Keywords: Eucalyptus camaldulensis; Glutathione; Green synthesis; Silver nanoparticles
Mesh:
Substances:
Year: 2020 PMID: 32434568 PMCID: PMC7238514 DOI: 10.1186/s40001-020-00415-4
Source DB: PubMed Journal: Eur J Med Res ISSN: 0949-2321 Impact factor: 2.175
Primers used in this study
| Target gene | Sequence primer (5′→3′) | Amplicon size (bp) | Annealing temperature | References | |
|---|---|---|---|---|---|
| AAGTGGAAAATTGGAGTGGAG | 130 | 60 °C | [ | ||
| GTAGTTGCCGACGACGATGAAG | |||||
| CGTGCTCAAGTGTTCAAGG | 294 | 60 °C | [ | ||
| TACAGTCGGAAAAGCCCAG | |||||
| GGGGGATCTTCGGACCTCA | 956 | 57 °C | [ | ||
| TCCTTAGAGTGCCCACCCG | |||||
The profiles of biofilm formation in P. aeruginosa in ½ MIC concentration of GS–Ag-NPs and Ag-NPs (P < 0.05)
| Isolates | Optical density [ | Optical density [ | ||
|---|---|---|---|---|
| Treatment | Control group | Treatment (Ag-NPs) | Control group | |
| (GSH–Ag-NPs) Mean ± SD | Mean ± SD | |||
| P.S*-1 | 1.12 ± 0.02 | 3.05 ± 0.084 | 1.34 ± 0.06 | 3.05 ± 0.084 |
| P.S -2 | 1.25 ± 0.05 | 3.75 ± 0.108 | 1.45 ± 0.08 | 3.75 ± 0.108 |
| P. S-3 | 1.01 ± 0.03 | 2.89 ± 0.049 | 1.14 ± 0.04 | 2.89 ± 0.049 |
| P.S-4 | 1.43 ± 0.1 | 3 ± 0.163 | 1.89 ± 0.12 | 3 ± 0.163 |
| P.S-5 | 1.30 ± 0.08 | 2.90 ± 0.089 | 1.5 ± 0.08 | 2.90 ± 0.089 |
| PS-6 | 0.90 ± 0.09 | 3 ± 0.143 | 1.02 ± 0.05 | 3 ± 0.143 |
| P.S-7 | 0.63 ± 0.03 | 3.5 ± 0.301 | 0.73 ± 0.03 | 3.5 ± 0.301 |
| P.S-8 | 0.55 ± 0.04 | 2.7 ± 0.184 | 0.65 ± 0.02 | 2.7 ± 0.184 |
| P.S-9 | 0.62 ± 0.05 | 3.12 ± 0.273 | 0.75 ± 0.04 | 3.12 ± 0.273 |
| P.S -10 | 0.76 ± 0.03 | 3.5 ± 0.187 | 0.95 ± 0.10 | 3.5 ± 0.187 |
| P.S-11 | 0.75 ± 0.04 | 2.95 ± 0.075 | 0.84 ± 0.07 | 2.95 ± 0.075 |
| P.S-12 | 0.63 ± 0.02 | 2.77 ± 0.140 | 0.75 ± 0.02 | 2.77 ± 0.140 |
| 0.60 ± 0.04 | 3 ± 0.216 | 0.85 ± 0.04 | 3 ± 0.216 | |
Fig. 1Agarose gel electrophoresis of las I and las R genes among the P. aeruginosa strains PCR products. M; size of DNA marker (50-bp), lane 1; (negative control) (PCR product of qnr A and qnr B gene) and lane 2; (positive control of las I gene), lane 3; (PCR product of las I gene in clinical strains), lane 4; (positive control of las R gene), lane 5; (PCR product of las R gene in clinical strains)
Fig. 2a Absorption spectrum of eucalyptus extract before adding silver nitrate; b absorption spectrum of eucalyptus extract after adding silver nitrate
Fig. 3SEM analysis of a silver nanoparticles; b glutathione-stabilized silver nanoparticles (GS–Ag-NPs)
Fig. 4Measurement of size distribution of nanoparticles
Fig. 5FTIR spectra of a Silver nanoparticles; b glutathione and c GS–Ag-NPs
Determination of MIC and MBC of Ag-NPs and GS–Ag-NPs agents against P. aeruginosa strains
| Bacterial strains | MIC (µg/ml) | MBC (µg/ml) | ||
|---|---|---|---|---|
| Ag-NPs | GS–Ag-NPs | Ag-NPs | GS–Ag-NPs | |
| 128 | 128 | 256 | 256 | |
| P.S*1 | 256 | 128 | 512 | 256 |
| P.S2 | 256 | 128 | 512 | 256 |
| P.S3 | 256 | 256 | 512 | 512 |
| P.S4 | 256 | 128 | 512 | 256 |
| P.S5 | 256 | 128 | 512 | 256 |
| P.S6 | 256 | 256 | 512 | 512 |
| P.S7 | 256 | 128 | 512 | 256 |
| P.S8 | 256 | 128 | 512 | 256 |
| P.S9 | 256 | 128 | 512 | 256 |
| P.S10 | 256 | 256 | 512 | 512 |
| P.S11 | 256 | 128 | 512 | 256 |
| P.S12 | 256 | 256 | 512 | 512 |
*PS: P. aeruginosa strain